Further measures to minimise risk of osteonecrosis of the jaw with bisphosphonate medicine

View source ↗

Summary

EMA announces enhanced risk-minimisation measures for osteonecrosis of the jaw associated with bisphosphonate medicines, including expanded patient information …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteonecrosis of the Jaw

Drugs mentioned

• bisphosphonate medicines